Podoplanin-positive cancer-associated fibroblasts predict poor prognosis in lung cancer patients
- PMID: 30254454
- PMCID: PMC6141120
- DOI: 10.2147/OTT.S175566
Podoplanin-positive cancer-associated fibroblasts predict poor prognosis in lung cancer patients
Abstract
Background: Cancer-associated fibroblasts (CAFs) are a heterogeneous population, and different subpopulations play differential roles in tumor microenvironment. However, the prognostic role of podoplanin-positive CAFs in human lung cancer still remains controversial.
Methods: Herein, we performed a meta-analysis including 12 published studies with 1,802 patients identified from PubMed and EBSCO to assess the prognostic impact of podoplanin-positive CAFs in lung cancer patients.
Results: We found that podoplanin+ fibroblast infiltration significantly decreased overall survival (OS), disease-free survival (DFS), and progression-free survival in patients. In stratified analyses, podoplanin+ fibroblast infiltration was significantly associated with worse OS and DFS in both squamous cell carcinoma and adenocarcinoma of lung. In addition, high density of podoplanin-positive CAFs significantly correlated with unfavorable clinicopathological features such as lymph node metastasis, and lymphatic, vascular, and pleural invasion of patients.
Conclusion: Podoplanin+ fibroblast infiltration leads to worse clinical outcome in lung cancer patients, implicating that it is a valuable prognostic biomarker and targeting it may have a potential for effective treatment.
Keywords: lung cancer; meta-analysis; podoplanin-positive cancer-associated fibroblasts; worse outcome.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures




Similar articles
-
Tumor-Infiltrating Podoplanin+ Fibroblasts Predict Worse Outcome in Solid Tumors.Cell Physiol Biochem. 2018;51(3):1041-1050. doi: 10.1159/000495484. Epub 2018 Nov 26. Cell Physiol Biochem. 2018. PMID: 30476924
-
Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients.J Cancer. 2018 Sep 8;9(20):3736-3742. doi: 10.7150/jca.28054. eCollection 2018. J Cancer. 2018. PMID: 30405845 Free PMC article.
-
Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.Ann Surg Oncol. 2012 Nov;19(12):3953-62. doi: 10.1245/s10434-012-2421-4. Epub 2012 Jun 6. Ann Surg Oncol. 2012. PMID: 22669451
-
Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.BMC Cancer. 2020 May 14;20(1):424. doi: 10.1186/s12885-020-06936-9. BMC Cancer. 2020. PMID: 32408907 Free PMC article.
-
The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.PeerJ. 2024 Feb 23;12:e16958. doi: 10.7717/peerj.16958. eCollection 2024. PeerJ. 2024. PMID: 38410801 Free PMC article.
Cited by
-
Prognostic impact of tumor microenvironment-related markers in patients with adenocarcinoma of the lung.Int J Clin Oncol. 2023 Feb;28(2):229-239. doi: 10.1007/s10147-022-02271-0. Epub 2022 Nov 14. Int J Clin Oncol. 2023. PMID: 36376711 Free PMC article.
-
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma.JTO Clin Res Rep. 2024 Dec 18;6(3):100779. doi: 10.1016/j.jtocrr.2024.100779. eCollection 2025 Mar. JTO Clin Res Rep. 2024. PMID: 40007550 Free PMC article.
-
A quantitative spatial cell-cell colocalizations framework enabling comparisons between in vitro assembloids and pathological specimens.Nat Commun. 2025 Feb 6;16(1):1392. doi: 10.1038/s41467-024-55129-6. Nat Commun. 2025. PMID: 39915493 Free PMC article.
-
Stromal Cells, Extracellular Matrix Components, and Adenosine A3 Receptor in Prostate Biopsies: Association With Histological Grade, PSA Levels, and Clinical Tumor Stage.J Histochem Cytochem. 2025 Jul 19:221554251349873. doi: 10.1369/00221554251349873. Online ahead of print. J Histochem Cytochem. 2025. PMID: 40682346 Free PMC article.
-
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker.BMC Cancer. 2024 Aug 9;24(1):987. doi: 10.1186/s12885-024-12703-x. BMC Cancer. 2024. PMID: 39123194 Free PMC article.
References
-
- Kubouchi Y, Yurugi Y, Wakahara M, et al. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma. Histopathology. 2018;72(3):490–499. - PubMed
-
- Yurugi Y, Wakahara M, Matsuoka Y, et al. Podoplanin expression in cancer-associated fibroblasts predicts poor prognosis in patients with squamous cell carcinoma of the lung. Anticancer Res. 2017;37(1):207–214. - PubMed
-
- Koriyamai H, Ishii G, Yoh K, et al. Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy. J Cancer Res Clin Oncol. 2015;141(7):1163–1170. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources